Browse > Article
http://dx.doi.org/10.5352/JLS.2019.29.6.747

Does the Gut Microbiota Regulate a Cognitive Function?  

Choi, Jeonghyun (Department of Physical Therapy, College of Healthcare Medical Science & Engineering, Inje University)
Jin, Yunho (Department of Physical Therapy, College of Healthcare Medical Science & Engineering, Inje University)
Kim, Joo-Heon (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University)
Hong, Yonggeun (Department of Physical Therapy, College of Healthcare Medical Science & Engineering, Inje University)
Publication Information
Journal of Life Science / v.29, no.6, 2019 , pp. 747-753 More about this Journal
Abstract
Cognitive decline is characterized by reduced long-/short-term memory and attention span, and increased depression and anxiety. Such decline is associated with various degenerative brain disorders, especially Alzheimer's disease (AD) and Parkinson's disease (PD). The increases in elderly populations suffering from cognitive decline create social problems and impose economic burdens, and also pose safety threats; all of these problems have been extensively researched over the past several decades. Possible causes of cognitive decline include metabolic and hormone imbalance, infection, medication abuse, and neuronal changes associated with aging. However, no treatment for cognitive decline is available. In neurodegenerative diseases, changes in the gut microbiota and gut metabolites can alter molecular expression and neurobehavioral symptoms. Changes in the gut microbiota affect memory loss in AD via the downregulation of NMDA receptor expression and increased glutamate levels. Furthermore, the use of probiotics resulted in neurological improvement in an AD model. PD and gut microbiota dysbiosis are linked directly. This interrelationship affected the development of constipation, a secondary symptom in PD. In a PD model, the administration of probiotics prevented neuron death by increasing butyrate levels. Dysfunction of the blood-brain barrier (BBB) has been identified in AD and PD. Increased BBB permeability is also associated with gut microbiota dysbiosis, which led to the destruction of microtubules via systemic inflammation. Notably, metabolites of the gut microbiota may trigger either the development or attenuation of neurodegenerative disease. Here, we discuss the correlation between cognitive decline and the gut microbiota.
Keywords
Cognitive decline; gut microbiota; gut metabolite;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Franceschi, F., Ojetti, V., Candelli, M., Covino, M., Cardone, S., Potenza, A., Simeoni, B., Gabrielli, M., Sabia, L., Gasbarrini, G., Lopetuso, L., Scaldaferri, F., Rossini, P. M. and Gasbarrini, A. 2019. Microbes and Alzheimer's disease: lessons from H. pylori and gut microbiota. Eur. Rev. Med. Pharmacol. Sci. 23, 426-430.
2 Frohlich, E. E., Farzi, A., Mayerhofer, R., Reichmann, F., Jacan, A., Wagner, B., Zinser, E., Bordag, N., Magnes, C., Frohlich, E., Kashoferm, K., Gorkiewicz, G. and Holzer, P. 2016. Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication. Brain Behav. Immun. 56, 140-155.   DOI
3 Funkhouser, L. J. and Bordenstein, S. R. 2013. Mom knows best: the universality of maternal microbial transmission. PLoS Biol. 11, e1001631.   DOI
4 Gefen, T., Kim, G., Bolbolan, K., Geoly, A., Ohm, D., Oboudiyat, C., Shahidehpour, R., Rademaker, A., Weintraub, S., Bigio, E. H., Mesulam, M. M., Rogalski, E. and Geula, C. 2019. Activated microglia in cortical white matter across cognitive aging trajectories. Front. Aging Neurosci. 11, 94.   DOI
5 Ghosh, S., Wu, M. D., Shaftel, S. S., Kyrkanides, S., LaFerla, F. M., Olschowka, J. A. and O'Banion, M. K. 2013. Sustained interleukin-$1{\beta}$ overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model. J. Neurosci. 33, 5053-5064.   DOI
6 Gray, M. T. and Woulfe, J. M. 2015. Striatal blood-brain barrier permeability in Parkinson's disease. J. Cereb. Blood Flow Metab. 35, 747-750.   DOI
7 Ho, J. T., Chan, G. C. and Li, J. C. 2015. Systemic effects of gut microbiota and its relationship with disease and modulation. BMC Immunol. 16, 21.   DOI
8 Holmgvist, S., Chutna, O., Bousset, L., Aldrin-Kirk, P., Li, W., Bjorklund, T., Wang, Z. Y., Roybon, L., Melki, R. and Li, J. Y. 2014. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 128, 805-820.   DOI
9 Ianiro, G., Tilg, H. and Gasbarrini, A. 2016. Antibiotics a s deep modulators of gut microbiota: between good and evil. Gut 65, 1906-1915.   DOI
10 Hoyles, L., Snelling, T., Umlai, U. K., Nicholson, J. K., Carding, S. R., Glen, R. C. and McArthur, S. 2018. Microbiome-host systems interaction: protective effects of propionate upon the blood-brain barrier. Microbiome 6, 55.   DOI
11 Isaacson, S. H., Boroojerdi, B., Waln, O., McGraw, M., Kreitzman, D. L., Klos, K., Revilla, F. J., Heldman, D., Phillips, M., Terricabras, D., Markowitz, M., Woltering, F., Carson, S. and Truong, D. 2019. Effect of using a wearable device on clinical decision-making and motor symptoms in patients with Parkinson's disease starting transdermal rotigotine patch: A pilot study. Parkinsonism Relat. Disord. S1353-8020, 30025-2.
12 Iyer, K. K., Au, T. R., Angwin, A. J., Copland, D. A. and Dissanayaka, N. N. W. 2019. Source activity during emotion processing and its relationship to cognitive impairment in Parkinson's disease. J. Affect. Disord. 253, 327-335.   DOI
13 Jagust, W. 2018. Imaging the evolution and pathophysiology of Alzheimer's disease. Nat. Rev. Neurosci. 19, 687-700.   DOI
14 Jin, Y., Choi, J., Won, J. and Hong, Y. 2018. The relationship between autism spectrum disorder and melatonin during fetal development. Molecules 23, E198.   DOI
15 Kakutani, S., Watanabe, H. and Murayama, N. 2019. Green tea intake and risks for dementia, Alzheimer's disease, mild cognitive impairment, and cognitive impairment: A systemic review. Nutrients 11, E1165.   DOI
16 Ho, P. W., Leung, C. T., Liu, H., Pang, S. Y., Lam, C. S., Xian, J., Li, L., Kung, M. H., Ramsden, D. B. and Ho, S. L. 2019. Age-dependent accumulation of oligomeric SNCA/${\alpha}$-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA). Autophagy 14, 1-24.   DOI
17 Minter, M. R., Taylor, J. M. and Crack, P. J. 2016. The contribution of neuroinflammation of amyloid toxicity in Alzheimer's disease. J. Neurochem. 136, 457-474.   DOI
18 Kashyap, G., Bapat, D., Das, D., Gowaikar, R., Amritkar, R. E., Rangarajan, G., Ravindranath, V. and Ambika, G. 2019. Synapse loss and progress of Alzheimer's disease -A network model. Sci. Rep. 9, 6555.   DOI
19 Kumar, M., Babaei, P. and Nielsen, J. 2016. Human gut microbiota and healthy aging: Recent developments and future prospective. Nutr. Healthy Aging 4, 3-16.   DOI
20 Li, X. J., Hong, X. Y., Wang, Y. L., Zhang, S. J., Zhang, J. F., Li, X. C., Liu, Y. C., Sun, D. S., Feng, Q., Ye, J. W., Gao, Y., Ke, D., Wang, Q., Li, H. L., Ye, K., Liu, G. P. and Wang, J. Z. 2019. Tau accumulation triggers STAT-1-dependent memory deficits by suppressing NMDA receptor expression. EMBO Rep. e47202.
21 Mutic, A. D., Jordan, S., Edwards, S. M., Ferranti, E. P., Thul, T. A. and Yang, I. 2017. The postpartum maternal and newborn microbiomes. MCN Am. J. Matern. Child Nurs. 42, 326-331.   DOI
22 Neufeld, K. M., Kang, N., Bienenstock, J. and Foster, J. A. 2011. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol. Motil. 23, 255-264.   DOI
23 Neuman, H., Forsythe, P., Uzan, A., Avni, O. and Koren, O. 2018. Antibiotics in early life: dysbiosis and the damage done. FEMS Microbiol. Rev. 42, 489-499.
24 Perez-Pardo, P., Dodiya, H. B., Engen, P. A., Forsyth, C. B., Huschens, A. M., Shaikh, M., Voigt, R. M., Nagib, A., Green, S. J., Kordower, J. H., Shannon, K. M., Garssen, J., Kraneveld, A. D. and Keshavarzian, A. 2019. Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice. Gut 68, 829-843.   DOI
25 Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Toth, M., Korecka, A., Bakocevic, N., Ng, L. G., Kundu, P., Gulyas, B., Halldin, C., Hultenby, K., Nilsson, H., Hebert, H., Volpe, B. T., Diamond, B. and Pettersson, S. 2014. The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med. 6, 263ra158.   DOI
26 Aagaard, K., Ma, J., Antony, K. M., Ganu, R., Petrosino, J. and Versalovic, J. 2014. The placenta harbors a unique microbiome. Sci. Transl. Med. 6, 237ra65.   DOI
27 Robbins, T. W. 2011. Cognition: the ultimate brain function. Neuropsychopharmacology 36, 1-2.   DOI
28 Akbari, E., Asemi, Z., Daneshvar, Kakhaki, R., Bahmani, F., Kouchaki, E., Tamtaji, O. R., Hamidi, G. A. and Salami, M. 2016. Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer's disease: A randomized, double-blind and controlled trial. Front. Aging. Neurosci. 8, 256.
29 Bagyinszky, E., Giau, V. V., Shim, K., Suk, K., An, S. S. A. and Kim, S. 2017. Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis. J. Neurol. Sci. 376, 242-254.   DOI
30 Baj, A., Moro, E., Bistoletti, M., Orlandi, V., Crema, F. and Giaroni, C. 2019. Glutamatergic signaling along the microbiota-gut-brain axis. Int. J. Mol. Sci. 20, E1482.   DOI
31 Browne, H. P., Veville, B. A., Forster, S. C. and Lawley, T. D. 2017. Transmission of the gut microbiota: spreading of health. Nat. Rev. Microbiol. 15, 531-543.   DOI
32 Saraswati, S. and Sitaraman, R. 2015. Aging and the human gut microbiota-from correlation to causality. Front. Microbiol. 5, 764.   DOI
33 Romo-Araiza, A., Gutierrez-Salmean, G., Galvan, E. J., Hernandez-Frausto, M., Herrera-Lopez, G., Romo-Parra, H., Garcia-Contreras, V., Fernandez-Presas, A. M., Jasso-Chavez, R., Borlongan, C. V. and Ibarra, A. 2018. Probiotics and prebiotics as a therapeutic strategy to improve memory on a model of middle-aged rats. Front. Aging Neurosci. 10, 416.   DOI
34 Saji, N., Niida, S., Murotani, K., Hisada, T., Tsuduki, T., Sugimoto, T., Kimura, A., Toba, K. and Sakurai, T. 2019. Analysis of the relationship between the gut microbiome and dementia: a cross-sectional study conducted in Japan. Sci. Rep. 9, 1008.   DOI
35 Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., Chesselet, M. F., Keshavarzian, A., Shannon, K. M., Krajmalnik-Brown, R., Wittung-Stafshede, P., Knight, R. and Mazmanian, S. K. 2016. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell 167, 1469-1480.   DOI
36 Sender, R., Fuchs, S. and Milo, R. 2016. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14, e1002533.   DOI
37 Shi, Y., Lu, X., Zhang, L., Shu, H., Gu, L., Wang, Z., Gao, L., Zhu, J., Zhang, H., Zhou, D. and Zhang, Z. J. 2019. Potential value of plasma Amyloid-${\beta}$, total tau and neurofilament light for identification of early Alzheimer's disease. ACS Chem. Neurosci. [Epub ahead of print].
38 Chen, W. W., Zhang, X. and Huang, W. J. 2016. Role of neuroinflammation in neurodegenerative disease (Review). Mol. Med. Rep. 13, 3391-3396.   DOI
39 Cai, H. Y., Yang, J. T., Wang, Z. J., Zhang, J., Yang, W., Wu, M. N. and Qi, J. S. 2018. Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer's disease. Biochem. Biophys. Res. Commun. 495, 1034-1040.   DOI
40 Carney, R. S. E. D. 2019. Estrogen-dominant ovarian cycle stages are associated with neural network dysfunction and cognitive and behavioral deficits in the hAPP-J20 mouse model of Alzheimer's disease. eNeuro 6, e0179.
41 Vina, J. and Sanz-Ros, J. 2018. Alzheimer's disease: Only prevention makes sense. Eur. J. Clin. Invest. 48, e13005.   DOI
42 Srivastav, S., Neupane, S., Bhurtel, S., Katila, N., Maharjan, S., Choi, H., Hong, J. T. and Choi, D. Y. 2019. Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity. J. Nutr. Biochem. 69, 73-86.   DOI
43 Chio, C. C., Chang, C. H., Wang, C. C., Cheong, C. U., Chao, C. M., Cheng, B. C., Yang, C. Z. and Chang, C. P. 2013. Etanercept attenuates traumatic brain injury in rats by reducing early microglial expression of tumor necrosis factor-${\alpha}$. BMC Neurosci. 14, 33.   DOI
44 Choi, J., Hur, T. Y. and Hong, Y. 2018. Influence of altered gut microbiota composition on aging and aging-related diseases. J. Lifestyle Med. 8, 1-7.   DOI
45 Choi, J., Lee, S., Won, J., Jin, Y., Hong, Y., Hur, T. Y., Kim, J. H., Lee, S. R. and Hong, Y. 2018. Pathophysiological and neurobehavioral characteristics of a propionic acid-mediated autism-like rat model. PLoS One 13, e0192925.   DOI
46 Collado, M. C., Rautava, S., Aakko, J., Isolauri, E. and Salminen, S. 2016. Human gut colonization may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci. Rep. 6, 23129.   DOI
47 Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X. N., Kubo, C. and Koga, Y. 2004. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J. Physiol. 558, 263-275.   DOI
48 Tian, P., Wang, G., Zhao, J., Zhang, H. and Chen, W. 2019. Bifidobacterium with the role of 5-hydroxytryptophan synthesis regulation alleviates the symptom of depression and related microbiota dysbiosis. J. Nutr. Biochem. 66, 43-51.   DOI
49 Wang, M. M., Miao, D., Cao, X. P., Tan, L. and Tan, L. 2018. Innate immune activation in Alzheimer's disease. Ann. Transl. Med. 6, 177.   DOI
50 Wang, T., Hu, X., Liang, S., Li, W., Wu, X., Wang, L. and Jin, F. 2015. Lactobacillus fermentum NS9 restores the antibiotic induced physiological and psychological abnormalities in rat. Benef. Microbes 6, 707-717.   DOI
51 Weil, R. S., Winston, J. S., Leyland, L. A., Pappa, K., Mahmood, R. B., Morris, H. R. and Rees, G. 2019. Neural correlates of early cognitive dysfunction in Parkinson's disease. Ann. Clin. Transl. Neurol. 6, 902-912.   DOI
52 Garcez, M. L., Jacobs, K. R. and Guillemin, G. J. 2019. Microbiota alterations in Alzheimer's disease: Involvement of the kynurenine pathway and inflammation. Neurotox. Res. [Epub ahead of print]
53 Dissanayaka, N. N. W., Lawson, R. A., Yarnall, A. J., Duncan, G. W., Breen, D. P., Khoo, T. K., Barker, R. A., Burn, D. J. and ICICLE-PD study group. 2017. Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease. Parkinsonism Relat. Disord. 36, 63-68.   DOI
54 Dodiya, H. B., Forsyth, C. B., Voigt, R. M., Engen, P. A., Patel, J., Shaikh, M., Green, S. J., Nagib, A., Roy, A., Kordower, J. H, Pahan, K., Shannon, K. M. and Keshavarzian, A. 2018. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease. Neurobiol. Dis. S0969-0061, 30768-X.
55 Erdo, F., Denes, L. and de Lange, E. 2017. Age-associated physiological and pathological changes at the blood-brain barrier: A review. J. Cereb. Blood Flow Metab. 37, 4-24.   DOI
56 Welcome, M. O. 2019. Gut microbiota disorder, gut epithelial and blood-brain barrier dysfunctions in etiopathogenesis of dementia: Molecular mechanisms and signaling pathways. Neuromolecular Med. [Epub ahead of print].
57 Woodmansey, E. J. 2007. Intestinal bacteria and ageing. J. Appl. Microbiol. 102, 1178-1186.   DOI